Disease Evolution Tracker Sensor Trailed in Leeds

Leeds trials wearable sensors designed to predict disease evolution.

12:25 07 September 2022

Medical device company WarnerPatch has teamed up with the Innovation Pop Up to trial remote monitoring technology with patients and clinicians at Leeds Teaching Hospitals NHS Trust. 

 

Melissa Berthelot, the company's founder and CEO, designed the wearable sensing mechanism to monitor the health of soft tissue to provide real-time indications of disease evolution. Powered by 5G, it is non-invasive and uses artificial intelligence to predict likely outcomes and generates alerts if symptoms get worse. 

 

Dr Berthelot said: “Our first goal is to target peripheral vascular disease, a progressive, chronic and incurable disease which affects 200 million people around the world and can cause embolism, stroke, pulmonary disorder and renal failure. It’s a gruesome disease.

 

“Clinicians can use WarnerPatch from the point they suspect the patient has the disease to gather vital data to enhance clinical diagnosis and decision making. We anticipate our trial will show that our medical device is acceptable to patients and clinicians and can improve quality of life, reduce emergency admissions and lengths of stay and prevent disease escalation.”